Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline
On Friday, Eyenovia, Inc. (NASDAQ:EYEN) stock is trading lower after an update from the Phase 3 CHAPERONE study evaluating ...
Monthly Prescribing Reference3y
Clobetasol Propionate
Clobetasol propionate 0.05%; crm; oint; gel; soln for scalp application. Treat infection if present; discontinue if infection persists or worsens. Do not use near eyes, or on diaper dermatitis or ...
Business Insider1mon
Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo
The presentation will detail the results of a successful Phase 3 study (CPN-302) of clobetasol propionate suspension 0.05% (APP13007) that led to its approval by the U.S. Food and Drug ...
Business Insider2d
Eyenovia’s Promising Growth Prospects: Buy Rating Affirmed by Analyst
Analyst Matthew Caufield of H.C. Wainwright reiterated a Buy rating on Eyenovia (EYEN – Research Report), with a price target of $12.00 ... along with the availability of Clobetasol, represent ...
Monthly Prescribing Reference5y
Clobetasol Propionate Emollient
Clobetasol propionate 0.05%; crm. Treat infection if present; discontinue if infection persists or worsens. Do not use near eyes, or on diaper dermatitis or pre-existing skin atrophy. Do not use ...
Stockhouse1mon
Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo
Presentation details efficacy and tolerability results from the successful Phase 3 program that led to FDA approval of clobetasol propionate suspension 0.05% for pain and inflammation following ocular ...
Yahoo Finance1mon
Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo
NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic technology company, today announced a presentation at the American Academy of Ophthalmology (AAO) 2024 Expo ...